Hungarian pharmaceuticals firm Richter has withdrawn its marketing application for one of its biosimilar drugs from the European Medicines Agency in anticipation of a possible negative assessment, the company said on Monday. More »
Richter received a positive opinion from European regulators recommending that its generic osteoporosis drug Terrosa be granted marketing authorization, the Hungarian drug maker said in a statement on Monday. More »
We use cookies!
By using this site you agree to the use of cookies, more info.